To include your compound in the COVID-19 Resource Center, submit it here.

Woodford backs AMO in $25M series A round

AMO Pharma Ltd. (London, U.K.) raised $25 million in a series

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE